Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits

Abstract

Our results define new hallmarks in molecular stratification and therapy options for patients at risk for HCC, and merit larger prospective investigations to develop a modified clinical-decision making algorithm based on the individualized next-generation sequencing analyses.